Effects of cyclodextrins on drug delivery through biological membranes

被引:255
|
作者
Loftsson, Thorsteinn
Vogensen, Stine Byskov
Brewster, Marcus E.
Konradsdottir, Fifa
机构
[1] Univ Iceland, Fac Pharm, IS-107 Reykjavik, Iceland
[2] Janssen Pharmaceut, Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium
关键词
cyclodextrin; drug delivery; unstirred water layer; water structure; permeation; membrane;
D O I
10.1002/jps.20992
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclodextrins have proven themselves to be useful functional excipients. Cyclodextrin derivatives can be hydrophilic or relatively lipophilic based on their substitution and these properties can give insight into their ability to act as permeability enhancers. Lipophilic cyclodextrins such as the methylated derivatives are thought to increase drug flux by altering barrier properties of the membrane through component extraction or fluidization. The hydrophilic cyclodextrin family also modulate drug flux through membranes but via different mechanisms. The current effort seeks to provide various explanations for these observations based on interactions of hydrophilic cyclodextrins with the unstirred water layer that separates the bulk media from biological membranes such as the gastric mucosa, cornea and reproductive tract. Theories on the serial nature of resistances to drug flux are used to explain why hydrophilic cyclodextrins can enhance drug uptake in some situation (i.e., for lipophilic material) but not in others. In addition, the nature of secondary equilibria and competition between cyclodextrins and rheologically important biopolymers such as mucin are assessed to give a complete picture of the effect of these starch derivatives. This information can be useful not only in understanding the actions of cyclodextrin but also in expanding their application and uses. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:2532 / 2546
页数:15
相关论文
共 50 条
  • [41] Hydrolyzable polyrotaxanes consisting of β-cyclodextrins and Pluronic® for drug delivery
    Ito, A
    Ooya, T
    Yui, N
    2004 INTERNATIONAL CONFERENCE ON MEMS, NANO AND SMART SYSTEMS, PROCEEDINGS, 2004, : 428 - 429
  • [42] Cooperative Drug Delivery through Molecular Communication among Biological Nanomachines
    Nakano, Tadashi
    Moore, Michael J.
    Okaie, Yutaka
    Enomoto, Akihiro
    Suda, Tatsuya
    2013 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS WORKSHOPS (IEEE ICC), 2013, : 809 - 812
  • [43] IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .41. BRAIN-ENHANCED DELIVERY OF CHLORAMBUCIL
    BODOR, N
    VENKATRAGHAVAN, V
    WINWOOD, D
    ESTES, K
    BREWSTER, ME
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 53 (03) : 195 - 208
  • [44] Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery
    Fahr, A
    van Hoogevest, P
    May, S
    Bergstrand, N
    Leigh, MLS
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 26 (3-4) : 251 - 265
  • [45] Lipid membranes: Biological inspiration for micro and nano encapsulation technologies, especially drug delivery
    Needham, D
    MATERIALS INSPIRED BY BIOLOGY, 2003, 774 : 173 - 202
  • [46] Controlled drug delivery through tailor-made blend polymeric membranes
    Stamatialis, DF
    Rolevink, HHM
    Balster, J
    Koops, GH
    JOURNAL OF CONTROLLED RELEASE, 2005, 101 (1-3) : 302 - 304
  • [47] The application of cyclodextrins in drug solubilization and stabilization of nanoparticles for drug delivery and biomedical applications
    Soe, Hay Man Saung Hnin
    Loftsson, Thorsteinn
    Jansook, Phatsawee
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 666
  • [48] Biological Barriers in Drug Delivery
    Mahurkar, H.
    Vaidya, Sunita N.
    ASIAN JOURNAL OF PHARMACEUTICS, 2024, 18 (02) : 380 - 393
  • [49] A wettability-based approach for the monitoring of drug transport through biological membranes
    Rochowski, P.
    Grzegorczyk, M.
    Pogorzelski, S.
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2019, 555 : 352 - 360
  • [50] Lipophilic drug transfer between liposomal and biological membranes: What does it mean for parenteral and oral drug delivery?
    Fahr, Alfred
    Van Hoogevest, Peter
    Kuntsche, Judith
    Leigh, Mathew L. S.
    JOURNAL OF LIPOSOME RESEARCH, 2006, 16 (03) : 281 - 301